LUMOS PHARMA INC. - C
3.8501
08-October-24 15:57:28
15 minutes delayed
Stocks
-0.0099
-0.26%
Today's range
3.6500 - 3.9400
ISIN
N/A
Source
NASDAQ
-
12 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD
29 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
14 Nov 2022 06:10:00 By Nasdaq GlobeNewswire
-
14 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
26 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
31 Aug 2022 09:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Announces Share Repurchase Program
16 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
09 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
27 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Upcoming Investor Conferences
16 May 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
10 May 2022 16:01:01 By Nasdaq GlobeNewswire
-
Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
26 Apr 2022 09:00:03 By Nasdaq GlobeNewswire
-
11 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Cantor Rare Disease Symposium
23 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
10 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Upcoming Investor Conferences
10 Mar 2022 09:00:01 By Nasdaq GlobeNewswire
-
Lumos Pharma to Report Full Year 2021 Financial Results and Host Conference Call on March 10, 2022
23 Feb 2022 09:00:01 By Nasdaq GlobeNewswire
-
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
05 Jan 2022 09:00:01 By Nasdaq GlobeNewswire